BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19823088)

  • 1. Pathogenesis of small vessel vasculitis associated with autoantibodies to neutrophil cytoplasmic antigens: new insights from animal models.
    Kain R; Firmin DA; Rees AJ
    Curr Opin Rheumatol; 2010 Jan; 22(1):15-20. PubMed ID: 19823088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis.
    Csernok E; Lamprecht P; Gross WL
    Curr Opin Rheumatol; 2010 Jan; 22(1):43-8. PubMed ID: 19770659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ANCA-small vessel vasculitides: what have we (not yet) learned from animal models?
    van der Veen BS; Heeringa P
    APMIS Suppl; 2009 Jun; (127):21-6. PubMed ID: 19515135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Animal models of systemic vasculitis.
    Mathieson PW; Qasim FJ; Esnault VL; Oliveira DB
    J Autoimmun; 1993 Apr; 6(2):251-64. PubMed ID: 8388693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of PR3-ANCA associated vasculitis.
    Kallenberg CG
    J Autoimmun; 2008; 30(1-2):29-36. PubMed ID: 18162369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insight into the pathogenesis of vasculitis associated with antineutrophil cytoplasmic autoantibodies.
    Jennette JC; Falk RJ
    Curr Opin Rheumatol; 2008 Jan; 20(1):55-60. PubMed ID: 18281858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunodiagnostic and pathophysiologic aspects of antineutrophil cytoplasmic antibodies in vasculitis.
    Gross WL; Csernok E
    Curr Opin Rheumatol; 1995 Jan; 7(1):11-9. PubMed ID: 7718417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis.
    Kallenberg CG
    Curr Opin Rheumatol; 2007 Jan; 19(1):17-24. PubMed ID: 17143091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of ANCA-associated vasculitis: recent insights from animal models.
    van Timmeren MM; Heeringa P
    Curr Opin Rheumatol; 2012 Jan; 24(1):8-14. PubMed ID: 22089093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shared idiotypy among patients with myeloperoxidase-anti-neutrophil cytoplasmic autoantibody associated glomerulonephritis and vasculitis.
    Nachman PH; Reisner HM; Yang JJ; Jennette JC; Falk RJ
    Lab Invest; 1996 Feb; 74(2):519-27. PubMed ID: 8780169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow-derived cells are sufficient and necessary targets to mediate glomerulonephritis and vasculitis induced by anti-myeloperoxidase antibodies.
    Schreiber A; Xiao H; Falk RJ; Jennette JC
    J Am Soc Nephrol; 2006 Dec; 17(12):3355-64. PubMed ID: 17108314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-neutrophil cytoplasmic antibody pathogenesis in small-vessel vasculitis: an update.
    Gómez-Puerta JA; Bosch X
    Am J Pathol; 2009 Nov; 175(5):1790-8. PubMed ID: 19815703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of vascular inflammation by anti-neutrophil cytoplasmic antibodies.
    Jennette JC; Xiao H; Falk RJ
    J Am Soc Nephrol; 2006 May; 17(5):1235-42. PubMed ID: 16624929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the evidence for antibodies to LAMP-2 in the pathogenesis of ANCA associated small vessel vasculitis?
    Kain R; Rees AJ
    Curr Opin Rheumatol; 2013 Jan; 25(1):26-34. PubMed ID: 23169102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. -463 G/A myeloperoxidase promoter polymorphism is associated with clinical manifestations and the course of disease in MPO-ANCA-associated vasculitis.
    Reynolds WF; Stegeman CA; Tervaert JW
    Clin Immunol; 2002 May; 103(2):154-60. PubMed ID: 12027420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newer insights into the aetiology and pathogenesis of myeloperoxidase associated autoimmunity.
    Schmitt WH
    Jpn J Infect Dis; 2004 Oct; 57(5):S7-8. PubMed ID: 15507771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies to neutrophil granule proteins: pathogenic potential in vasculitis?
    Locke IC; Cambridge G
    Br J Biomed Sci; 1996 Dec; 53(4):302-16. PubMed ID: 9069109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology of ANCA-associated vasculitides: are ANCA really pathogenic?
    Tervaert JW; Heeringa P
    Neth J Med; 2003 Dec; 61(12):404-7. PubMed ID: 15025415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased membrane expression of proteinase 3 during neutrophil adhesion in the presence of anti proteinase 3 antibodies.
    Brachemi S; Mambole A; Fakhouri F; Mouthon L; Guillevin L; Lesavre P; Halbwachs-Mecarelli L
    J Am Soc Nephrol; 2007 Aug; 18(8):2330-9. PubMed ID: 17634439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-neutrophil cytoplasmic autoantibodies and leukocyte-endothelial interactions: a sticky connection?
    Heeringa P; Huugen D; Tervaert JW
    Trends Immunol; 2005 Nov; 26(11):561-4. PubMed ID: 16139567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.